Primary Hepatic Leiomyosarcoma: A Case Series Highlighting a Rare Malignancy [0.03%]
原发性肝平滑肌肉瘤：一个罕见恶性肿瘤的病例系列分析
Divya Khosla,Treshita Dey,Rakesh Kapoor et al.
Divya Khosla et al.
Objectives: Primary hepatic leiomyosarcoma (PHLMS) is an exceedingly rare malignant tumor originating from the liver with only a handful of cases reported in literature. Herein, we present five cases of PHLMS diagnosed an...
Prognostic Impact of Initial Laboratory-based Scores for Hepatocellular Carcinoma Patients: A Retrospective Study [0.03%]
基于实验室检查的肝细胞癌预后评分系统的回顾性研究
Walid I Yousif,Mohamed F Bakosh
Walid I Yousif
Background/aim: Hepatocellular carcinoma (HCC) is a heterogeneous tumor with variable prognosis. We aimed to evaluate different laboratory-based scores and indices to predict 1-year overall survival (OS). ...
Impact of Resistance Associated Substitutions and Predictors of Treatment Failure Following Direct-acting Antiviral Therapy in a Viral Hepatitis C Elimination Cohort [0.03%]
直接抗病毒治疗后丙型肝炎病毒消除队列中耐药相关置换及治疗失败预测因素的影响
Madhumita Premkumar,Ekta Gupta,Anchal Sandhu et al.
Madhumita Premkumar et al.
Background: The National Viral Hepatitis Control Program (NVHCP) has a cure rate of 91.6% when using direct-acting antivirals (DAAs)-sofosbuvir with an NS5A inhibitor (ledipasvir, daclatasvir or velpatasvir) ± ribavirin ...
Plasma Exchange With Corticosteroids as a Rescue Therapy for Severe Prolonged Cholestasis in Acute Viral Hepatitis [0.03%]
重症急性病毒性肝炎严重持续胆汁淤积的挽救疗法：皮质类固醇联合血浆置换疗法
Sunil Taneja,Rohit Mehtani,Chandragiri P Ganesh et al.
Sunil Taneja et al.
Background and aims: Prolonged cholestasis after acute viral hepatitis (AVH) complicates 6 weeks with peak serum bilirubin >10 mg/dL, in the absence of haemolysis and renal failure with alanine transferase level below 500...
Prevalence of Binge Eating Disorder in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis [0.03%]
代谢功能障碍相关肝脂肪变性疾病中暴食症的流行率：一项荟萃分析
Lubna Al-Sharif,Samira M Khalil,Matheus Souza
Lubna Al-Sharif
Spleen Area Affects the Performance of the Platelet Count-Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease Cirrhosis [0.03%]
基于血小板计数的非侵入性工具预测代谢功能异常相关肝硬化患者首次发生肝失代偿事件的价值受脾脏体积影响：队列研究
Marcello Dallio,Mario Romeo,Fiammetta Di Nardo et al.
Marcello Dallio et al.
Background/aims: Various non-invasive tools (NITs) predicting first hepatic decompensation (HD) in advanced chronic liver disease (ACLD) enclose platelet (PLT) count. A relevant proportion of metabolic dysfunction-associa...
Surendran Sudhindran,Anil C Anand
Surendran Sudhindran
Lifestyle Intervention is Effective in Reversal of Fibrosis in NAFLD Patients: Results from a Retrospective Real-World Study [0.03%]
生活方式干预可逆转非酒精性脂肪肝患者的肝纤维化：一项回顾性真实世界研究结果
Shivaram P Singh,Prajna Anirvan,Swati Chouhan et al.
Shivaram P Singh et al.
Background: Nonalcoholic fatty liver disease (NAFLD) is a lifestyle disorder, and lifestyle intervention (LI) remains the cornerstone of NAFLD management. Despite this, in recent years, the focus has been primarily on dev...
Mortality and Liver-related Outcomes in Patients with Decompensated Liver Disease and Hepatogenous Diabetes [0.03%]
肝病失代偿期患者与肝脏糖尿病相关的结果和死亡率
Gourab Bhaduri,Kalyani Sridharan,Tanmay Jain et al.
Gourab Bhaduri et al.
Background: Hepatogenous diabetes (HD) is a less defined entity which refers to abnormal glucose metabolism occurring as a consequence of liver cirrhosis (LC). This prospective cohort study aimed to examine the effect of ...
Arun Gupta,Raghav Seth,Ajit Yadav et al.
Arun Gupta et al.
Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer worldwide and ranks third in terms of cancer related mortality. The management options for earlystage HCC include surgical resection, liver transplantation and percutan...